Literature DB >> 15516834

Protamine enhances uptake of cationic liposomes in angiogenic microvessels.

M E Eichhorn1, S Strieth, S Krasnici, B Sauer, M Teifel, U Michaelis, K Naujoks, M Dellian.   

Abstract

INTRODUCTION: Cationic liposomes have been shown to target angiogenic endothelial cells of solid tumours. Supposing a charge-related mechanism might be responsible for liposome-endothelial interaction, we investigated the effect of intravenous pre-injection of the charged molecules protamine, a polycationic protein, and fucoidan, a polyanionic polysaccharide on the accumulation of cationic liposomes within the blood vessels of a solid tumour.
MATERIALS AND METHODS: Experiments were performed using the amelanotic hamster melanoma A-Mel-3 growing in a dorsal skinfold chamber of hamsters. Accumulation of fluorescently-labelled cationic liposomes was quantified by intravital macroscopy and digital image analysis of tumour (t) and surrounding normal host tissue (n) over an observation period of 6 h. All animals received an i.v. injection of cationic liposomes. Animals of the control group were pre-treated with an i.v. injection of 0.9% saline, while animals of group 2 received positively charged protamine and animals of group 3 negatively charged fucoidan prior to liposome injection.
RESULTS: In control animals i.v. injection of cationic liposomes revealed a preferential targeting of the tumour vessels, indicated by a maximal t/n ratio of 2.2 +/- 0.24 and a maximal fluorescence intensity (fmax) corresponding to the tumour of 66 +/- 12 [% standard]. While there were no significant differences of liposome accumulation within normal host tissue, accumulation of cationic liposomes within the tumour was significantly enhanced after the pre-administration of protamine (fmax: 117 +/- 12 [% standard]). The t/n ratio was significantly increased in protamine pre-treated animals (5.3 +/- 1.7) in comparison to control and fucoidan treated animals. In contrast, pre-injection of fucoidan resulted in reduced maximal fluorescence intensities in tumour (47 +/- 8 [% standard]) and normal surrounding host tissue.
CONCLUSION: Pre-administration of protamine increases the accumulation of cationic liposomes in a solid tumour animal model causing an increased selectivity of cationic liposomes in targeting angiogenic microvessels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516834     DOI: 10.1007/s10456-004-1428-2

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  5 in total

1.  Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer.

Authors:  Sebastian Strieth; Christoph Dunau; Kristina Kolbow; Ruth Knuechel; Uwe Michaelis; Hannelore Ledderose; Martin E Eichhorn; Donata Strelczyk; Uta Tschiesner; Barbara Wollenberg; Marc Dellian
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-27       Impact factor: 2.503

2.  Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth.

Authors:  Khuloud T Al-Jamal; Wafa' T Al-Jamal; Simon Akerman; Jennifer E Podesta; Açelya Yilmazer; John A Turton; Alberto Bianco; Neil Vargesson; Chryso Kanthou; Alexander T Florence; Gillian M Tozer; Kostas Kostarelos
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

Review 3.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

Review 4.  Molecular targeting of liposomal nanoparticles to tumor microenvironment.

Authors:  Gang Zhao; B Leticia Rodriguez
Journal:  Int J Nanomedicine       Date:  2012-12-28

5.  The role of nanomedicine in cell based therapeutics in cancer and inflammation.

Authors:  Rasika M Samarasinghe; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Int J Mol Cell Med       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.